10:30–11:00:

Returning to Pathogen Specificity with Antibody Therapy

 

Arturo Casadevall, M.D., Ph.D.

Albert Einstein College of Medicine

11:00–11:30:

Challenges in Antimicrobial Susceptibility Testing of Clinical and Environmental Isolates

 

Fred Tenover, Ph.D., D(ABMM), F(AAM), F(IDSA)

Cepheid

11:30–12:00:

Clinical Management Issues, Outcomes

 

Louis B. Rice, M.D.

Louis Stokes Cleveland VA Medical Center

12:00–12:30:

Discussion of Session III

12:30–1:15:

Lunch

Session IV
Think Globally, Act Regionally (and Locally): Panel Discussion on Prudent Use, Stewardship, Global Engagement, Incentives: How Do We Get from Where We Are to Where We Want to Be?

Moderators: David Heymann, M.D., and James Hughes, M.D.

1:15–2:15:

Prudent Use, Stewardship, Market Incentives, and Global Engagement

 

Stuart Levy, M.D., Tufts University and the Alliance for Prudent Use of Antibiotics

 

Shelley Hearne, Ph.D., The Pew Charitable Trusts

 

Jeffrey Levi, Ph.D., Trust for America’s Health

2:15–4:30:

Open Discussion with Panelists, Forum Members, and Audience

 

Julian Davies, Ph.D., University of British Columbia

Gerard Wright, Ph.D., McMaster University

Jørgen Schlundt, Ph.D., D.V.M., World Health Organization

Brad Spellberg, M.D., University of California, Los Angeles

Ed Cox, M.D., M.P.H., Food and Drug Administration/Center for Drug Evaluation and Research

4:30–5:00:

James Hughes, M.D., and David Relman, M.D., Wrap-Up and Adjournment

5:00:

Meeting Adjourns



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement